Newly Diagnosed

Social Security Administration Demystifies the Benefits Process - 2023 MDF Annual Conference

Presented on September 8th, 2023.

Diana Varela, Public Affairs Specialist
Social Security Administration

Joyce Lee, Medical Relations Officer
Department on Disability Services

Gain a better understanding of the role of the Social Security Administration (SSA) programs, benefits, and services available to the DM community in the US. Leaders from the SSA will join this panel to help demystify the application, denial, and appeal process.

Click here to learn more about the 2023 MDF Annual Conference.

DM1 Disease Development & Symptom Management - 2023 MDF Annual Conference

Presented on September 8th, 2023.

Johanna Hamel, MD
University of Rochester Medical Center

This session is ideal for those new to the DM1 community and those seeking a refresher. Learn from a leading expert about the causes and genetics underlying DM1, how and when in life it can affect different symptoms of the body, tips for self-management of symptoms, and how to best work with your clinical care team to ensure the best quality of life.

Click here to learn more about the 2023 MDF Annual Conference.

DM2: Disease Development, Symptoms, & Management

Originally presented on September 10th. 2021 as a part of the DM2 Track at the 2021 Virtual MDF Annual Conference.

Learn about genetic factors causing DM2, the different body systems affected, the most common symptoms, and how best to manage and provide care for the disease from a leading expert. Appropriate for newly diagnosed and those living with DM2 for many years.

Speakers include:

  • Johanna Hamel, MD
  • Lindsey Baker, PT
  • Araya Pwanant, MD

DM1: Disease Development, Symptoms, & Management

Originally presented on September 10th, 2021 as a part of the DM1 Track at the 2021 Vitual MDF Annual Conference.

Learn about genetic factors causing DM1, the different body systems affected, the most common symptoms, and how best to manage and provide care for the disease from a leading expert. Appropriate for newly diagnosed and those living with DM1 for many years.

Presented by Jacinda Sampson, MD, PhD.

Myotonic Dystrophy Resources

 

Learn about the different resources that have been created for the Myotonic Dystrophy community! This presentation provides an introduction to help familiarize you with the resources and support options available for families affected by myotonic dystrophy.

The resources discussed during this video can be found at:

For newly diagnosed families, we recommend the following resources:

Have questions? Need more help? Contact us!

Caring for the Caregiver

 

Presented during Myotonic's Friday Afternoon Webinar Series.

Identify and learn how to manage your responsibilities as a caregiver. Learn how to recognize, understand, and respond to the emotional challenges of being a caregiver. Explore stress management techniques and learn of the resources available for caregivers and care receivers. Be sure to check out the resouces discussed during the presentation.

About the Presenter:

Valeria Ochoa, Southern Caregiver Resource Center (SCRC)

Valeria Ochoa is a Community Educator for the Southern Caregiver Resource Center (SCRC). She travels San Diego County holding bilingual classes, training sessions, and workshops for community groups and caregivers. Valeria’s education in Public Health, experience working with diverse communities, and extensive background in health disparities make her an excellent advocate for caregivers. She continues to educate and empower communities and connect individuals to vital services offered by the Southern Caregiver Resource Center.

How Common is Myotonic Dystrophy in the United States? Findings from the Recent Prevalence Study

 

Presented during Myotonic's Friday Afternoon Webinar Series.

This presentation will discuss the outcome of the recent study exploring the prevalence of myotonic dystrophy type 1 in the United States. We will discuss the study, the first of its kind focused on myotonic dystrophy, including how common we now believe the disease to be in the general population, how that number as determined, implications for ongoing testing for DM1 in the general population, and what it may mean for helping advance DM1 treatment and drug development.

About the Presenter: Dr. Nicholas Johnson treats adults and children with both common and rare neuromuscular conditions, yet his work doesn’t end in the clinic. He dedicates significant time each week to laboratory research, and is part of a team at VCU Health working to advance the treatment of genetic muscle disorders, with a special emphasis on muscular dystrophies. Dr. Johnson is board-certified in neurology, neuromuscular medicine and neuromuscular pathology by the American Academy of Neurology, and serves on its government relations committee.